Agenda

May 1-2, 2024 · Boston, MA

All-Access Pass Holders can attend all agenda sessions and will have access to speaker presentations after the event. Agenda sessions are subject to change. Check back often for updates and additions.

Register Now

Expand All +
  • April 30, 2024

    Tuesday

  • May 1, 2024

    Wednesday

  • May 2, 2024

    Thursday

  • This pre-conference session is available to All-Access Pass holders, Sponsor All-Access pass holders and Speakers. The workshop requires a $100 refundable deposit to secure a spot. Lunch is included. Add on during registration.
    Where
    50

  • Join us as we kick off the Robotics Summit and DeviceTalks Boston in style with music, games, networking, and more! Light food and drinks will be served. Tickets required; free to sponsors and speakers, $35 for All-Access and Expo Only pass holders that purchase pre-event. $50 tickets purchased on site.
    Where
    160ABC

  • DeviceTalks Editorial Director, Tom Salemi and MedTech Innovator CEO, Paul Grand welcome attendees to DeviceTalks Boston 2024.
    Where
    160ABC

  •  
    Where
    160ABC

  • For two decades, Elizabeth McCombs has been driving the development of new medical devices. As EVP and Chief Technology Officer at BD, McCombs now is responsible for overseeing BD’s innovation pipeline and executing on the company’s strategy to power smarter, more connected care within the hospital and in new settings, like the home, while promoting better outcomes for patients living with chronic illnesses. In this discussion, McCombs will share her career journey and explain how BD is deploying new tools, technologies, and methodologies to get the job done.
    Keynote
    Where
    160ABC

  •  
    Where
    Exhibit Hall C

  •  
    Bringing Products to Market
    Where
    159

  •  
    Innovation & Investment Forum
    Where
    160ABC

  • Stryker, a global leader in medical technologies, has been at the forefront of additive manufacturing innovation for more than a decade. Stryker’s mission – together with our customers, we are driven to make healthcare better – provides a north star for culture and living our purpose. Stryker’s Global AMagine® Institute has led the industry in developing cutting-edge additive manufacturing technology, resulting in game-changing products to make healthcare better. This talk will delve into how Stryker uses additive manufacturing to develop, industrialize and innovate new healthcare solutions across joint replacement, spine, and other medical applications.
    Manufacturing & Materials
    Where
    162A

  • Baxter’s Chief of Digital Platforms & Innovation Donny Patel will lead a conversation around connected care – the current landscape, the opportunities and challenges the industry faces in advancing connected care, and what the future looks like for device connectivity in the hospital setting and beyond.
    New Tools & Tech
    Where
    162B

  •  
    New Product Development
    Where
    161

  • In tandem with AI, the transformative potential of computational modeling and simulation is set to revolutionize clinical trials, providing a compelling vision of how these advanced digital technologies can minimize risks, cut costs, and expedite the product approval process. Medical device development has already employed modeling and simulation for product development and early-stage product testing. The latest advances now allow for continued operations in virtual environments throughout the clinical trial stage. This includes generating virtual patient cohorts for treatment arms and synthetic patients for control arms, offering an innovative approach to trial design, and streamlining the assessment of novel treatments. This session will explore the convergence of these technologies and present compelling evidence of progress, including recent collaborative efforts with the FDA in developing a groundbreaking blueprint for utilizing these advanced approaches, representing a significant step towards a more efficient and patient-centric future in device development.
    New Product Development
    Where
    161

  • Join Tecan’s technology development group, Emphysys, as we delve into the intricacies of complex MedTech system design through advanced engineering techniques. Discover the essentials of the 'optimizer tool' and its application in balancing multiple, often conflicting, device requirements to achieve the most effective solutions. We'll unpack how a deeper analysis of subsystem designs not only uncovers the most optimized solutions but also crafts a detailed blueprint for navigating future design challenges. This discussion aims to provide valuable insights into strategic decision-making in design, underscoring the importance of adopting optimization early in the development process for significant time and cost savings.
    Manufacturing & Materials
    Where
    162A

  • Next-generation MedTech systems have made generational leaps in connected, intelligent functionality, leading to improved patient diagnostics, care and outcomes. Yet despite the gains, patients are largely still tethered to the hospital bed, slowing down the recovery process. Portrait™ Mobile by GE HealthCare was approved by the FDA in 2023 as a first-of-its-kind, continuous monitoring solution that enables patients to move around the hospital while providing uninterrupted oversight. Real-time, uninterrupted data flow monitors vital signs regardless of where the patient is, providing continuous trending and actionable alarms for immediate event detection and treatment. The backbone of Portrait Mobile is data-centric software that is based on Data Distribution Service (DDS™), the publish-subscribe middleware standard. This data-centric software architecture enables flexible, real-time and continuous connectivity for mobile monitoring. The data framework also addresses the simultaneous and demanding interoperability, reliability, cybersecurity, safety and performance requirements. This talk will provide an introduction to DDS, followed by a discussion of how DDS is used in Portrait Mobile architecture to deliver highly-reliable information flow over a mobile, distributed system.
    New Tools & Tech
    Where
    162B

  •  
    Bringing Products to Market
    Where
    159

  • Join medtech VCs and CEOs as they delve into strategies for positioning your medtech company to attract investors, collaborators, and acquirers. Intellectual Property (IP) is critical for medtech companies to attract funding, strategic partners, and navigate an exit through M&A or IPO. To become attractive funding or M&A targets, medtech companies must prioritize de-risking and aligning their commercial, regulatory, and IP strategies. Gain insights into best practices and pitfalls to avoid when building strategic patent portfolios to close funding, stay competitive, and secure a successful exit.
    Where
    160ABC

  • Distalmotion is a medical device company founded in Lausanne, Switzerland with a mission to empower robotic surgery to more hospitals, surgeons, and patients worldwide. Distalmotion is commercial with multiple installations across France, Germany, and Switzerland. Its surgical robot Dexter® is designed to offer Simplicity, Accessibility and Excellence. It delivers the benefits of robotics to more hospitals by being simple and straightforward to use, and more accessible as a modular, small format, and open system. As an open system, Dexter is designed to work natively with third party 3D imaging systems, energy devices, vessel sealers and other laparoscopic devices. It has a suite of fully wristed single use instruments providing the user with dexterity, precision of movement, reliable instrument performance, and lower reprocessing requirements.
    Bringing Products to Market
    Where
    159

  •  
    New Product Development
    Where
    161

  •  
    Manufacturing & Materials
    Where
    162A

  •  
    New Tools & Tech
    Where
    162B

  •  
    Innovation & Investment Forum
    Where
    160ABC

  • Learn how to incorporate biocompatibility testing into the design process of medical devices and drug delivery systems, aligning with ISO 10993 and other relevant standards. This presentation by PSN Labs provides guidance on material selection, manufacturing techniques, and device design to ensure biocompatibility from early development stages. Discover how to address evolving regulations and scientific advancements to prevent late-stage biocompatibility issues in the final product. Gain insights into strategies for identifying appropriate biological evaluation plans based on device classification. By integrating biocompatibility considerations into design, manufacturers enhance patient safety, streamline regulatory compliance, and minimize risks of delays and recalls. Join us to explore key aspects of biocompatible device design and learn how to proactively address challenges for successful product development.
    New Product Development
    Where
    161

  •  
    Manufacturing & Materials
    Where
    162A

  •  
    New Tools & Tech
    Where
    162B

  • Medtech lawyers Matt Wetzel & Steve Tjoe will share their views in a lightning round talk format on the top legal and regulatory issues facing the medtech and diagnostic industry today, developments we can expect in 2024, and key watch-outs for the industry. Leveraging their combined experience, Steve (previously a lawyer at FDA’s CDRH) and Matt (former AdvaMed Deputy GC and GRAIL Chief Compliance Officer), will highlight several areas, including continued enforcement actions related to customer relationships; FDA’s diagnostic and laboratory developed test (LDT) initiatives, third-party litigation funding, ethylene oxide & sterilization, proposals to bridge the coverage “valley of death,” integrity of third-party generated data, and top trends in digital health regulation.
    Where
    160ABC

  •  
    Bringing Products to Market
    Where
    159

  •  
    Keynote
    Where
    160ABC

  •  
    Where
    Exhibit Hall C

  • Connect with MedTech colleagues from around the world to recap Day 1 of the show, catch up with old friends and create new connections. Tickets required; free to All-Access Sponsors, Speakers, and All-Access pass holders. $45 for Expo Only Sponsors and Expo Only Pass holders that purchase pre-event. $60 tickets purchased on site
    Where
    SE Pre-function Level 1

  • Join medtech industry peers for an hour of networking, engagement, and mentorship (and food and drink, of course). Find a mentor, reach out to a new contact, reconnect, and help foster a movement that needs more female leadership at all levels. Ticket required; Open to all-access pass holders, speakers and sponsors – $25/person (limited availability, must be purchased pre-event)
    Where
    162A

  • In this panel, we’ll talk with the executive team leading CMR Surgical’s global launch of Versius, a robotic surgical system designed to assist surgeons perform laparoscopic surgery. How does Versius’ design, functionality and size differ from other systems currently in the market?
    Keynote
    Where
    160ABC

  •  
    Where
    Exhibit Hall C

  •  
    Where
    162B

  • Makers of even the most disruptive new devices may have a difficult time gaining share in markets where large device companies dominate. But hope is not lost. Start-ups can deploy innovative new tools and tactics to level the playing field. In this panel, chief commercial leaders will share the tricks of the trade that are helping them build a business.
    Bringing Products to Market
    Where
    161

  •  
    Manufacturing & Materials
    Where
    162A

  • AI's potential for disrupting the medical device industry is undeniable. Major players are making strategic moves to solidify their position in the future of medtech: acquisitions, newly established executive roles devoted to AI, and partnerships with tech leaders like NVIDIA all signal a commitment to integration. This session will feature AI leaders from Medtronic, Boston Scientific, and Sanofi sharing insights into their AI strategies, specific use cases showcasing current successes, and their vision for how AI will reshape the industry in years to come.
    New Tools & Tech
    Where
    159

  •  
    Innovation & Investment Forum
    Where
    160ABC

  • You don't know what you don't know. When it comes to micro component design and development, what seems like a minor decision can make a major impact on the cost, manufacturing efficiency, and repeatability of your product. Join our machining and metals-based manufacturing experts as they discuss how material selection, reviewing your design with the end user in mind, rapid prototyping, designing for automation and scalability, and more can influence the success of your RAS project.
    Where
    162B

  • Innovation is expensive, and third-party component suppliers are an integral part of the make or buy decision along the R&D journey toward commercialization and manufacturing of new medical devices. Join us for a discussion about evaluating the onboarding of new suppliers and products, quality and change control, supporting documentation, safety stock and business continuity.
    Where
    162A

  •  
    Where
    159

  • Recent years have seen exciting developments in smart implants – from closed-loop neuromodulation systems, wirelessly connected artificial joints, dual-chamber leadless pacemakers, to brain-computer interfaces. Many more are on the way, fuelled by a fusion of biomedical research, new technology and ambitious innovation. In this talk we review the emerging landscape of implantable therapies, where trends are taking us next, and offer strategies to navigate the challenges and complexities of this space while meeting the needs of patients, regulators and innovators.
    Where
    160ABC

  •  
    Where
    Exhibit Hall C

  • The shortage of nursing staff is proving to be an intractable problem for the U.S. healthcare system, both in terms of cost and, most importantly, negative impact on patient care and outcomes. In this panel, panelists will explore the scope of the problem and identify how a multi-pronged, device-driven strategy can help by streamlining care workflows, lowering costs, and improving patient outcomes.
    Manufacturing & Materials
    Where
    162A

  •  
    Innovation & Investment Forum
    Where
    160ABC

  • Medtronic and its Structural Heart and Aortic teams are committed to driving healthcare equity and improving access around the world to life-saving technologies for patients with heart disease. However, these technologies are only as impactful as the ability to bring them to the patients and communities that need them most. Through clinical trials targeting participation from underserved communities, Medtronic is looking specifically at how heart disease affects women and ethnic minority groups differently, and how that data can potentially re-shape the future of treatment for underserved populations with heart disease.
    New Product Development
    Where
    161

  •  
    Bringing Products to Market
    Where
    159

  • Many medtech startup founders reach a point where experience outweighs entrepreneurship and a new CEO is needed to push their company forward. In this session, a panel of seasoned medtech leaders share the important lessons they learned to ensure a smooth hand off and to find the fastest path to the finish line.
    Where
    160ABC

  • Robots. Artificial intelligence. Real-time. Remote. We can only predict what surgery will look like in 50 or 100 years, but one thing will always be true: the patient and surgeon will always be at the center. It is a serious and even sacred relationship. And the same is true for the surgeon and the technology they use. It’s not about the bits or bytes, it’s about how the tools help best meet each patient’s unique needs, to deliver the best possible outcome. Join Rajit as he goes beyond robots to explore the fascinating and exciting intersection of people and technology shaping the future of surgery. Spoiler, there will be robots and AI—and beyond.
    Keynote
    Where
    258ABC

  •  
    Where
    160ABC